Abiomed (ABMD) Misses Q1 View By A Penny; Re-affirms FY10 Revenue Guidance

August 6, 2009 10:16 AM EDT Send to a Friend

Abiomed (Nasdaq: ABMD) reports Q1 EPS of ($0.21) versus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Abiomed (ABMD) Misses Q1 View By A Penny; Re-affirms FY10 Revenue Guidance

Member Login

Free News Feed